Explore the Global Hormonal Contraception Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Hormonal Contraception Market

Key Insight

Hormonal Contraception Market is forecast to increase from USD 21.46 Billion in 2025 to USD 35.63 Billion by 2036, at a projected CAGR of 5.2%. In terms of product, Oral Contraceptive Pills is expected to hold the largest share at 40.2%, while Combined Hormonal Contraceptive will account for a 58.7% share in the hormones segment.

April 01, 2026

Anurag Sharma

250 Pages

Cite this Report

Hormonal Contraception Market

https://www.futuremarketinsights.com/reports/hormonal-contraception-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

The Vanguard Group
Afaxys
Agile Therapeutics
Bayer
Church & Dwight Co. Inc
Janssen Pharmaceuticals Inc
Lupin Pharmaceuticals
Merck KGaA
Pregna International Ltd
Teva Pharmaceuticals Industries Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Hormonal Contraception Market

Key Players

Similar Industry Reports